Evidence map›Paper›PMID 27680737›Full record

ReviewDer Internist2016

[Management of axial spondyloarthritis].

U Kiltz, X Baraliakos, J Braun

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Internist, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

U KiltzRheumazentrum Ruhrgebiet, Claudiusstr. 45, 44649, Herne, Deutschland. uta.kiltz@elisabethgruppe.de.
X BaraliakosRheumazentrum Ruhrgebiet, Claudiusstr. 45, 44649, Herne, Deutschland.
J BraunRheumazentrum Ruhrgebiet, Claudiusstr. 45, 44649, Herne, Deutschland.
Charité - Universitätsmedizin Berlin · DERheumazentrum Ruhrgebiet · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The term spondyloarthritis (SpA) is now increasingly used to classify and diagnose patients who are characterized by inflammation in the axial skeleton and peripheral manifestations (arthritis and enthesitis). The management of SpA should be tailored according to the current manifestations of the disease, the disease activity and functional impairment. The current article focuses on diagnosis and therapy in patients with axial SpA. Diagnostic procedures are discussed in light of diagnostic utility and feasibility in daily routine care. Cornerstones of treatment in patients with axial SpA are a combination of regular exercise and pharmacological treatment options aiming at anti-inflammatory strategies.

Indexed as

Anti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalBiological ProductsCombined Modality TherapyEvidence-Based MedicineExercise TherapyHumansPatient Care ManagementSpondylitis, AnkylosingTreatment OutcomeAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalBiological ProductsAnti-inflammatory agents, non-steroidalBiologicsExerciseSacroiliitisSpondylitis, ankylosing

Identifiers

PMID27680737
OpenAlexW198064845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.